WELCOME TO THE SECOND ISSUE OF THE BSi
This publication highlights events, opportunities, and accomplishments from the BSi community.
Drug Discovery in Academia Conference
On October 18-19, 2011 BSi hosted scientists, administrators, and entrepreneurs for an un-precedented discussion of “The New Paradigm for Drug Discovery.” The conference featured presenters from recently established academic drug discovery centers as well as prominent pharmaceutical companies, disease foundations, and venture capital firms. Discussion centered on outlining best practices and guidelines for emerging partnerships between academia and industry. Read the full article.
Academic Drug Discovery Consortium
Following a proposal by BSi leadership, drug discovery scientists from the BSi and JHU, Vanderbilt, Harvard, UCSF, and UNC have agreed to organize an Academic Drug Discovery Consortium (ADDC). The consortium will facilitate the exchange of technical expertise, educational materials and guidance for emerging drug discovery initiatives, and will bolster advocacy to funding agencies. A central repository website will catalogue U.S. drug discovery programs, academia-pharma collaborations, job postings, and academic projects available for licensing. Read the full article
JHU to Collaborate with Eisai
Tokyo-based pharmaceutical company Eisai is the newest addition to the BSi’s roster of industry partners. Brain-based targets are a major focus for Eisai and cutting-edge research at Hopkins routinely identifies potentially relevant therapeutic targets for a number of brain conditions. Under this unique new agreement, Eisai will use assays developed and validated by BSi’s Neuro- Translational program to execute high-throughput screening to identify compounds that interact with Hopkins-identified therapeutic targets. Eisai is also equipped to execute the studies necessary to move promising targets toward FDA approval. Read the full article
SYNAPSES, CIRCUITS AND COGNITIVE DISORDERS
The SCCD program plans to recruit 1-2 new faculty members in 2012 and is currently interviewing candidates. Danny O’Conner, a research specialist at the HHMI Janelia Farm Research Campus was hired by the program last year and will begin setting up his lab at the BSi beginning this June. O’Connor’s research focuses on cortical circuits underlying sensory perception.
After review by a panel of external and internal investigators, the BSi awarded funding to three research proposals aimed at elucidating the “Mechanisms Underlying Acute and Chronic Pain” and five proposals in Neurotranslational Research. Funding awards for Neurotranslational Research are ongoing with proposals being accepted each June and funding decisions announced in the fall. The BSi is currently reviewing all applications submitted for research in the area of “Traumatic Brain Injury: Mechanisms and Treatment”.
The BSi has announced the formation of three new working groups aimed at fostering research progress in: Autism, the Blood Brain Barrier, and Hearing/Sound/Music. These meetings will bring together Hopkins researchers, with interest in these areas, to exchange ideas and explore potential interdisciplinary collaborations. Working groups for Pain, Neural Regeneration, and Traumatic Brain Injury continue to meet on a regular basis.
View upcoming working group meetings